Through multi-omics integration and functional verification, this study revealed for the first time its pivotal role in the tumor space immune microenvironment and its therapeutic target value in AML, laying the foundation for the development of precision treatment based on HOXA5 molecular typing. The gene discussed is HOXA5; the disease is neoplasm.